Treatment of PMR is still largely based on glucocorticoids. Where in other inflammatory rheumatic disorders, such as RA and PsA, early initiation of methotrexate is common practice, this is not the case in PMR.
Read Article
Aatke van der Maas is a rheumatologist working in the Sint Maartenskliniek in The Netherlands. This is a specialized hospital in rheumatology, orthopedics, rehabilitation and pain treatment, serving as a secondary and tertiary referral center for movement related healthcare in The Netherlands. She also works there as a senior researcher with special interest in polymyalgia rheumatica, focusing on treatment options in PMR.